Key statistics
On Friday, Pulse Biosciences Inc (PLSE:NAQ) closed at 17.87, -21.24% below its 52-week high of 22.69, set on Aug 23, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 18.78 |
---|---|
High | 18.91 |
Low | 17.59 |
Bid | 17.50 |
Offer | 18.30 |
Previous close | 18.73 |
Average volume | 196.93k |
---|---|
Shares outstanding | 61.29m |
Free float | 17.04m |
P/E (TTM) | -- |
Market cap | 1.10bn USD |
EPS (TTM) | -0.7916 USD |
Data delayed at least 15 minutes, as of Sep 20 2024 21:00 BST.
More ▼
- Pulse Biosciences Reports Business Updates and Preliminary Second Quarter 2024 Financial Results
- Pulse Biosciences, Inc. Appoints Paul LaViolette to Its Board of Directors
- Pulse Biosciences, Inc. Announces Successful Treatment of Patients in First-in-Human Study with its Nano-PFA Cardiac Surgery System
- Pulse Biosciences, Inc. Announces Participation in Upcoming Investor Conferences
- Pulse Biosciences Schedules Second Quarter 2024 Financial Results Conference Call for August 12, 2024
- Pulse Biosciences, Inc. Announces Receipt of FDA Breakthrough Device Designation for CellFX® nsPFA Cardiac Surgery System for the Treatment of Atrial Fibrillation
- Pulse Biosciences, Inc. Announces the Closing of its Rights Offering
- Pulse Biosciences, Inc. Announces Preliminary Results for its Rights Offering
More ▼